# Trade Mark Journal No.2025/048 28 November 2025

## UK00004295930 17 November 2025 (9)

COMET

International priority date claimed: 8 October 2025 (United States of America) (99433235)

Class 9
  Electronic analyzers other than for medical use for testing and analyzing tissues and chemical and biological substances for the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms, for research and laboratory use; detecting, testing, inspecting apparatus and instruments for research and laboratory use in the field of immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing, namely, multiplexors, and hyperplex imaging apparatus for use in spatial biology, to discover, test, and validate biomarkers, and describe the composition and spatial distribution of cells, and the activity of the immune response occurring within organisms affected by cancer; laboratory apparatus and instruments for use in immunohistochemistry, in situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing, namely, microscopes, and optical profilers; laboratory apparatus, instruments and devices for biology, microfluidics and bioanalysis, namely, integrated circuits, microfluidic chips in the nature of integrated circuits, DNA chips, biochips for research or scientific purposes, microchips, microfluidic microchips, micro lab-on-chips, namely, microchips, microprocessors, microfluidic microprocessors, and measurement sensors other than for medical use used to measure biomarker expression levels in samples; analysis apparatus for research and laboratory use other than for medical use for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing, namely, research laboratory analyzers for multi-omics analysis of cells, tissues, and chemical and biological samples, for evaluation of elution efficiency and marker's epitope stability in samples, and for checking and controlling fluidic processes for high-precision reagent delivery and incubation; microfluidic analysis apparatus other than for medical use for research and laboratory use in the field of sequential immunofluorescence; microfluidic systems, namely, sample processing devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubes, reservoirs, pumps and microsensors for the study and analysis of chemical and biological samples; electronic imaging devices for laboratory use for generating, reconstructing, analyzing, monitoring, segmenting, quantifying and storing microscope images of chemical and biological samples.

Lunaphore Technologies SA

Representative: Daneel Williams LLP